Thomas Lönngren

indications are approved that could increase sales, the important patents will be out of date. A solution to this extends far beyond the mandate of the EMA. Are the different legislations in the pharmaceutical field that influence, and steer, the way research is done properly coordinated with one another? We may need to take a more holistic view of the life… CONTINUE READING